LONDON, May 13, 2014 /PRNewswire/ --
The US markets saw a positive sentiment on Monday, May 12, 2014, with the NASDAQ Composite closing at 4,143.86, up 1.77%, the Dow Jones Industrial Average ending the session 0.68% higher at 16,695.47, and the S&P 500 edging 0.97% higher to finish the trading session at 1,896.65. During the session gains in the Information Technology, Industrials and Materials sectors positively impacted the broader market, while some retraction came in from Utilities and Telecommunication Services sectors. A number of stocks saw large movements, including Gogo Inc. (NASDAQ: GOGO), VeriFone Systems Inc. (NYSE: PAY), Depomed Inc. (NASDAQ: DEPO) and TESARO Inc. (NASDAQ: TSRO). Free technical research on GOGO, PAY, DEPO and TSRO can be downloaded upon signing up at:
On Monday, Gogo Inc.'s stock fluctuated between $12.36 and $13.20 before ending the session 6.20% higher at $12.67. Gogo Inc.'s stock reported a trading volume of 9.64 million shares, above to its three months average volume of 3.40 million shares. Gogo Inc.'s shares have declined 0.08% in the previous three trading sessions, 30.35% in the last one month and 48.96% on YTD basis. The S&P 500 Information Technology Sector Index registered a gain of 1.48% during the trading session, and it has charted up 4.43% in the last one month. The stock is trading below its 50-day and 200-day moving averages of $19.42 and $19.58, respectively. Moreover, shares of the company have a Relative Strength Index (RSI) of 26.80. On the same day, Gogo Inc. announced its Q1 2014 financial results. For Q1 2014, the company reported net loss attributable to Gogo Inc. of $16.9 million, or $0.20 per share. Sign up today to read free research on GOGO at:
VeriFone Systems Inc.'s stock finished Monday's session 8.78% higher at $34.94. A total of 4.56 million shares were traded, which was much above its three months average volume of 1.59 million shares. The stock moved between $33.34 and $34.98 during the session. VeriFone Systems Inc.'s stock has advanced 11.95% in the last one month and 23.07% in the previous three months. Additionally, from the beginning of 2014, the stock has gained an upside of 30.28%. The S&P 500 Information Technology Sector Index mapped a gain of 1.48% during the trading session, and the same charted up 2.48% in the last three months. The company's shares are trading above their 50-day and 200-day moving averages. Moreover, the stock's 50-day moving average of $32.49 is greater than its 200-day moving average of $26.16. VeriFone Systems Inc.'s stock traded at a PE ratio of 48.80 and has an RSI of 46.90. Sign up today to read free research on PAY at:
On Monday, Depomed Inc.'s stock rallied 13.53%, closing the day at $12.00. The stock recorded a trading volume of 2.47 million shares, much above its three months average volume of 1.16 million shares. The stock oscillated between $11.20 and $12.83 during the trading session. Over the last one month and over the previous three months, Depomed Inc.'s shares have fallen by 7.41% and 3.69%, respectively. However, the stock has advanced 13.42% since the beginning of 2014. Shares of the company traded at a PE ratio of 10.52. The S&P 500 Health Care Sector Index reported a gain of 1.04% during the trading session and charted up 4.74% in the last one month. The stock is trading above its 200-day moving average of $10.02, while the 200-day moving average is below Depomed Inc.'s 50-day moving average of $13.67. Additionally, the stock has an RSI of 28.64. Sign up today to read free research on DEPO at:
On Monday, shares in TESARO Inc. recorded a trading volume of 1.78 million shares, higher than its three months average volume of 0.36 million shares. The stock ended the day at $29.05, which was 20.99% above its previous day's closing, and registered an intraday range of $26.66 and $29.49. TESARO Inc.'s shares have surged 21.75% in the previous three trading sessions, 19.11% in the last one month and 2.87% on YTD basis. The S&P 500 Health Care Sector Index mapped a gain of 1.04% during the trading session, and the index has charted up 1.47% in the last three months. The company's stock is trading above its 50-day moving averages of $28.62. Furthermore, shares of the company have an RSI of 41.83. On May 12, 2014, TESARO Inc. announced positive top-line results from the third and final Phase 3 trial of rolapitant. Sign up today to read free research on TSRO at:
1. This is not company news. We are an independent source and our views do not reflect the companies mentioned.
2. Information in this release is produced on a best efforts basis by Rohit Tuli, a CFA charterholder. The content is then further fact checked and reviewed by an outsourced research provider. However, we are only human and are prone to make mistakes. If you notice any errors or omissions, please notify us below.
3. This information is submitted as a net-positive to companies mentioned, to increase awareness for mentioned companies to our subscriber base and the investing public.
4. If you wish to have your company covered in more detail by our team, or wish to learn more about our services, please contact us at pubco [at] http://www.investor-edge.com.
5. For any urgent concerns or inquiries, please contact us at compliance [at] http://www.investor-edge.com.
6. Are you a public company? Would you like to see similar coverage on your company? Send us a full investors' package to research [at] http://www.investor-edge.com for consideration.
Content is researched, written and reviewed on a best-effort basis. This document, article or report is prepared and authored by Investor-Edge, represented by Rohit Tuli, CFA. An outsourced research services provider has only reviewed the information provided by Investor-Edge in this article or report according to the procedures outlined by Investor-Edge. Investor-Edge is not entitled to veto or interfere in the application of such procedures by the outsourced provider to the articles, documents or reports, as the case may be.
NOT FINANCIAL ADVICE
Investor-Edge makes no warranty, expressed or implied, as to the accuracy or completeness or fitness for a purpose (investment or otherwise), of the information provided in this document. This information is not to be construed as personal financial advice. Readers are encouraged to consult their personal financial advisor before making any decisions to buy, sell or hold any securities mentioned herein.
NO WARRANTY OR LIABILITY ASSUMED
Investor-Edge is not responsible for any error which may be occasioned at the time of printing of this document or any error, mistake or shortcoming. No liability is accepted by Investor-Edge whatsoever for any direct, indirect or consequential loss arising from the use of this document. Investor-Edge expressly disclaims any fiduciary responsibility or liability for any consequences, financial or otherwise arising from any reliance placed on the information in this document. Investor-Edge does not (1) guarantee the accuracy, timeliness, completeness or correct sequencing of the information, or (2) warrant any results from use of the information. The included information is subject to change without notice.
CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.